International safety notice

Urgent Field Safety Notice for Atellica DCA HbA1c Dx Reagent by Siemens Healthcare Diagnostics Inc. Tarrytown

Germany / BfArM · DEU · Feb 27, 2023

Key facts

Title Urgent Field Safety Notice for Atellica DCA HbA1c Dx Reagent by Siemens Healthcare Diagnostics Inc. Tarrytown
Regulator Germany / BfArM
Country DEU
Brand Atellica DCA HbA1c Dx Reagent
Manufacturer Siemens Healthcare Diagnostics Inc. Tarrytown
Models 09160956, ‐8.60, 00630414298054, ‐15.70, 02062, ‐5.19, 08630911, 10888771, ‐4.50, 00630414285696, 23-006.A.OUS, 006AOUS and 4 more
Date Feb 27, 2023
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices